LRMR
Price
$3.08
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
193.04M
39 days until earnings call
UBX
Price
$0.77
Change
-$0.02 (-2.53%)
Updated
Jun 27 closing price
Capitalization
13.28M
Interact to see
Advertisement

LRMR vs UBX

Header iconLRMR vs UBX Comparison
Open Charts LRMR vs UBXBanner chart's image
Larimar Therapeutics
Price$3.08
Change-$0.00 (-0.00%)
Volume$346
Capitalization193.04M
Unity Biotechnology
Price$0.77
Change-$0.02 (-2.53%)
Volume$54.34K
Capitalization13.28M
LRMR vs UBX Comparison Chart in %
Loading...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LRMR vs. UBX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMR is a Buy and UBX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (LRMR: $3.08 vs. UBX: $0.77)
Brand notoriety: LRMR and UBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LRMR: 0% vs. UBX: 17%
Market capitalization -- LRMR: $193.04M vs. UBX: $13.28M
LRMR [@Biotechnology] is valued at $193.04M. UBX’s [@Biotechnology] market capitalization is $13.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LRMR’s FA Score shows that 1 FA rating(s) are green whileUBX’s FA Score has 0 green FA rating(s).

  • LRMR’s FA Score: 1 green, 4 red.
  • UBX’s FA Score: 0 green, 5 red.
According to our system of comparison, LRMR is a better buy in the long-term than UBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LRMR’s TA Score shows that 6 TA indicator(s) are bullish while UBX’s TA Score has 4 bullish TA indicator(s).

  • LRMR’s TA Score: 6 bullish, 4 bearish.
  • UBX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than UBX.

Price Growth

LRMR (@Biotechnology) experienced а +18.92% price change this week, while UBX (@Biotechnology) price change was -5.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

LRMR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($193M) has a higher market cap than UBX($13.3M). LRMR (-20.413) and UBX (-20.995) have similar YTD gains . UBX has higher annual earnings (EBITDA): -24.46M vs. LRMR (-105.02M). LRMR has more cash in the bank: 158M vs. UBX (16.9M). LRMR has less debt than UBX: LRMR (4.87M) vs UBX (18.7M). LRMR (0) and UBX (0) have equivalent revenues.
LRMRUBXLRMR / UBX
Capitalization193M13.3M1,451%
EBITDA-105.02M-24.46M429%
Gain YTD-20.413-20.99597%
P/E RatioN/AN/A-
Revenue00-
Total Cash158M16.9M935%
Total Debt4.87M18.7M26%
FUNDAMENTALS RATINGS
LRMR vs UBX: Fundamental Ratings
LRMR
UBX
OUTLOOK RATING
1..100
7439
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4264
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (22) in the null industry is in the same range as UBX (52) in the Biotechnology industry. This means that LRMR’s stock grew similarly to UBX’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as UBX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to UBX’s over the last 12 months.

LRMR's SMR Rating (100) in the null industry is in the same range as UBX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to UBX’s over the last 12 months.

LRMR's Price Growth Rating (42) in the null industry is in the same range as UBX (64) in the Biotechnology industry. This means that LRMR’s stock grew similarly to UBX’s over the last 12 months.

LRMR's P/E Growth Rating (100) in the null industry is in the same range as UBX (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to UBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LRMRUBX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 19 days ago
86%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TURB2.370.05
+2.35%
Turbo Energy SA
CPAY327.041.00
+0.31%
Corpay
CCOI48.200.04
+0.08%
Cogent Communications Holdings
AMRK21.16-0.75
-3.42%
A-Mark Precious Metals
LOOP1.34-0.05
-3.60%
Loop Industries

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
N/A
ERAS - LRMR
51%
Loosely correlated
N/A
ACLX - LRMR
51%
Loosely correlated
+0.90%
IMNM - LRMR
50%
Loosely correlated
-0.23%
SYRE - LRMR
48%
Loosely correlated
-4.99%
IMVT - LRMR
48%
Loosely correlated
N/A
More

UBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, UBX has been loosely correlated with LRMR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if UBX jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UBX
1D Price
Change %
UBX100%
-1.73%
LRMR - UBX
35%
Loosely correlated
N/A
HOFBF - UBX
34%
Loosely correlated
N/A
ABCL - UBX
33%
Loosely correlated
-3.48%
MNMD - UBX
33%
Poorly correlated
-2.82%
JSPR - UBX
33%
Poorly correlated
-3.51%
More